[HTML][HTML] EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

European Association for the Study of the Liver - Journal of hepatology, 2015 - Elsevier
Liver fibrosis is part of the structural and functional alterations in most chronic liver diseases.
It is one of the main prognostic factors as the amount of fibrosis is correlated with the risk of
developing cirrhosis and liver-related complications in viral and non-viral chronic liver
diseases [1],[2]. Liver biopsy has traditionally been considered the reference method for
evaluation of tissue damage such as hepatic fibrosis in patients with chronic liver disease.
Pathologists have proposed robust scoring system for staging liver fibrosis such as the semi …